【摘要】 背景与目的 基质金属蛋白酶7（matrix metalloproteinase 7, MMP-7）又称基质溶解素，是MMPs家族成 , also known as matrilysin, is a member of the MMP family. The objectives of this study were to test MMP-7 protein levels in the peripheral blood of lung cancer patients and healthy control subjects and to determine their corresponding clinical significance. Methods Peripheral blood samples were obtained from 114 lung cancer patients and 100 healthy control subjects. MMP-7 protein levels in the plasma were measured by enzyme-linked immunosorbent assay. Results The plasma protein levels of MMP-7 in lung cancer patients (median=0.72 ng/mL) were significantly higher than those in healthy control subjects (median=0.30 ng/mL)(P<0.001).
sex, smoking status, tumor size, pathological classification, as well as lymphatic metastasis and stage (P>0.05).
Conclusion
The plasma protein levels of MMP-7 increase in the peripheral blood of lung cancer patients. Peripheral blood MMP-7 can be used as a tumor marker for detecting lung cancer. The fact that no significant correlation between the protein levels of MMP-7 and lung cancer clinical parameters was observed in this study warrants further analysis in larger samples.
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MMP-7在消化道肿瘤的进展期存在过表达现象，如食
管 [9] 、胃 [10] 、结肠 [11] 、肝 [12] 和胰腺 [13] 。Liu等 [14] 研究了
MMP-7在人类肺腺癌A549细胞系中的表达及作用，提示
MMP-7与肺癌细胞增殖、凋亡相关。 www.lungca.org www.lungca.org www.lungca.org
